S10 Ep23: Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa

from OncLive® On Air · host OncLive® On Air

Dr Wagner discusses current unmet needs for patients with PEComa, how ongoing research aims to address some of these gaps, and how findings from the AMPECT trial in particular support the use of nab-sirolimus in patients with advanced malignant disease.

Episode metadata supplied by the publisher feed · Published Mar 28, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep23: Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa

0:00 15:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 15 minutes long.

When was this OncLive® On Air episode published?

This episode was published on March 28, 2024.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!